Quarterly report · Q1
2590.TEDINET S100O6IT
Period2022-01-21 → 2022-04-20
Filed2022-06-03
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥34.8bn | 2022-01-21 → 2022-04-20 | Cons. | Net sales |
| Revenue | ¥162.6bn | 2021-01-21 → 2022-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.1bn | 2021-01-21 → 2021-04-20 | Cons. | Net sales |
| Operating income | −¥692m | 2022-01-21 → 2022-04-20 | Cons. | Operating income |
| Operating income | ¥426m | 2021-01-21 → 2021-04-20 | Cons. | Operating income |
| Ordinary income | −¥585m | 2022-01-21 → 2022-04-20 | Cons. | Ordinary income |
| Ordinary income | ¥5.7bn | 2021-01-21 → 2022-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥400m | 2021-01-21 → 2021-04-20 | Cons. | Ordinary income |
| Profit before tax | −¥676m | 2022-01-21 → 2022-04-20 | Cons. | Income before income taxes |
| Profit before tax | ¥431m | 2021-01-21 → 2021-04-20 | Cons. | Income before income taxes |
| Net income (owners) | −¥857m | 2022-01-21 → 2022-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.0bn | 2021-01-21 → 2022-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥229m | 2021-01-21 → 2021-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥860m | 2022-01-21 → 2022-04-20 | Cons. | Profit loss |
| Net income | ¥217m | 2021-01-21 → 2021-04-20 | Cons. | Profit loss |
| Total assets | ¥163.8bn | at 2022-04-20 | Cons. | Assets |
| Total assets | ¥159.0bn | at 2022-01-20 | Cons. | Assets |
| Total assets | ¥163.5bn | at 2021-04-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥82.1bn | at 2022-04-20 | Cons. | Liabilities |
| Total liabilities | ¥75.7bn | at 2022-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥81.7bn | at 2022-04-20 | Cons. | Net assets |
| Net assets / equity | ¥83.3bn | at 2022-01-20 | Cons. | Net assets |
| Net assets / equity | ¥83.8bn | at 2021-04-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.4bn | at 2022-04-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.6bn | at 2022-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥-54.78 | 2022-01-21 → 2022-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥254.2 | 2021-01-21 → 2022-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.72 | 2021-01-21 → 2021-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.6% | at 2022-04-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.0% | at 2021-04-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-04-20 | −¥270m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥325m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥96m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | ¥234m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥205m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥2.9bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥2.7bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥120m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥28m |
| —segment total | revenue | 2022-01-21 → 2022-04-20 | ¥34.9bn |
| —segment total | revenue external | 2022-01-21 → 2022-04-20 | ¥34.8bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥134m |
| —segment total | segment profit | 2022-01-21 → 2022-04-20 | −¥422m |
| Reconciling Itemsreconciling | revenue | 2021-01-21 → 2021-04-20 | −¥126m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-21 → 2021-04-20 | −¥126m |
| Reconciling Itemsreconciling | segment profit | 2021-01-21 → 2021-04-20 | −¥367m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2021-01-21 → 2021-04-20 | ¥26.9bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2021-01-21 → 2021-04-20 | ¥26.9bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-04-20 | ¥15m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2021-01-21 → 2021-04-20 | ¥707m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2021-01-21 → 2021-04-20 | −¥44m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2021-01-21 → 2021-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2021-01-21 → 2021-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2021-01-21 → 2021-04-20 | ¥143m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2021-01-21 → 2021-04-20 | ¥2.4bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2021-01-21 → 2021-04-20 | ¥2.4bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2021-01-21 → 2021-04-20 | −¥30m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2021-01-21 → 2021-04-20 | ¥2.7bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2021-01-21 → 2021-04-20 | ¥2.6bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2021-01-21 → 2021-04-20 | ¥109m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2021-01-21 → 2021-04-20 | ¥17m |
| —segment total | revenue | 2021-01-21 → 2021-04-20 | ¥36.3bn |
| —segment total | revenue external | 2021-01-21 → 2021-04-20 | ¥36.1bn |
| —segment total | revenue intersegment | 2021-01-21 → 2021-04-20 | ¥126m |
| —segment total | segment profit | 2021-01-21 → 2021-04-20 | ¥793m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 393
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 26923000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 2366000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 2693000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4293000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 36277000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -126000000 | JPY |
| Net sales | Prior1YTDDuration | 36150000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 707000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -30000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 17000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 143000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | -44000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 793000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -367000000 | JPY |
| Operating income | Prior1YTDDuration | 426000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 24760000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 2992000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 2731000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4311000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 34795000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 34795000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 12000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 120000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 134000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -134000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | 24773000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | 2992000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | 2851000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 4312000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | － | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 34930000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -134000000 | JPY |
| Net sales | CurrentYTDDuration | 34795000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DomesticBeverageBusinessReportableSegmentsMember | -325000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000InternationalBeverageBusinessReportableSegmentsMember | -205000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000PharmaceuticalRelatedBusinessReportableSegmentsMember | -28000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000FoodBusinessReportableSegmentsMember | 234000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00424-000DyDoPharmaReportableSegmentsMember | -96000000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -422000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -270000000 | JPY |
| Operating income | CurrentYTDDuration | -692000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |